BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37178249)

  • 21. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.
    Damke E; Tsuzuki JK; Cortez DA; Ferreira IC; Bertoni TA; Batista MR; Donati L; Svidzinski TI; Consolaro ME
    BMC Complement Altern Med; 2011 May; 11():35. PubMed ID: 21542936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Novel Chimeric Endolysin Conjugated with Chitosan-Zn-Metal-Organic Framework Nanocomposites with Antibacterial Activity.
    Malekian M; Fahimi H; Niri NM; Khaleghi S
    Appl Biochem Biotechnol; 2024 Feb; 196(2):616-631. PubMed ID: 37166650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo analysis of monotherapy and dual therapy with ethyl caffeate and fluconazole on virulence factors of Candida albicans and systemic candidiasis.
    Wang T; Pan M; Xiao N; Wu J; Wang Q; Cheng T; Yan G; Wu D; Li N; Shao J
    J Glob Antimicrob Resist; 2021 Dec; 27():253-266. PubMed ID: 34700054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan coated Ag/ZnO nanocomposite and their antibiofilm, antifungal and cytotoxic effects on murine macrophages.
    Thaya R; Malaikozhundan B; Vijayakumar S; Sivakamavalli J; Jeyasekar R; Shanthi S; Vaseeharan B; Ramasamy P; Sonawane A
    Microb Pathog; 2016 Nov; 100():124-132. PubMed ID: 27622344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of resistance and sensitivity of 1 200 strains of vulvovaginal candidiasis in China to five common antifungal drugs].
    Fan LY; Liu ZH; Bai XN; Zong X
    Zhonghua Fu Chan Ke Za Zhi; 2022 Aug; 57(8):601-607. PubMed ID: 36008287
    [No Abstract]   [Full Text] [Related]  

  • 26. Naringenin-Zinc Oxide Nanocomposites Amalgamated Polymeric Gel Augmented Drug Delivery and Attenuated Experimental Cutaneous Candidiasis in Balb/c Mice: In Vitro and In Vivo Studies.
    Katta CB; Bahuguna D; Veerabomma H; Gollapalli S; Shaikh AS; Bhale NA; Dikundwar AG; Kaki VR; Singh PK; Madan J
    AAPS PharmSciTech; 2024 Jun; 25(5):130. PubMed ID: 38844611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Response of
    Salama OE; Gerstein AC
    Antimicrob Agents Chemother; 2022 May; 66(5):e0240621. PubMed ID: 35446135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced systematic delivery of fluconazole-loaded biotin-glutathione functionalized chitosan-g-proline carrier into the infected retinitis treatment.
    Guo Q; Li Z; Cao F
    BMC Ophthalmol; 2024 Jan; 24(1):48. PubMed ID: 38291379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against
    Nikoomanesh F; Falahatinejad M; Černáková L; Dos Santos ALS; Mohammadi SR; Rafiee M; Rodrigues CF; Roudbary M
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109701
    [No Abstract]   [Full Text] [Related]  

  • 30. Potential of Methylglyoxal-Conjugated Chitosan Nanoparticles in Treatment of Fluconazole-Resistant
    Khan SH; Younus H; Allemailem KS; Almatroudi A; Alrumaihi F; Alruwetei AM; Alsahli MA; Khan A; Khan MA
    Int J Nanomedicine; 2020; 15():3681-3693. PubMed ID: 32547022
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Sobel JD; Borroto-Esoda K; Azie N; Angulo D
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0056221. PubMed ID: 34001513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis.
    Feng W; Yang J; Ji Y; Xi Z; Yang L; Zhu X; Ma Y
    Lett Appl Microbiol; 2020 Feb; 70(2):95-101. PubMed ID: 31705810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic chitosan nanoparticles loaded with Amphotericin B: Synthesis, properties and potentiation of antifungal activity against common human pathogenic fungal strains.
    Zareshahrabadi Z; Khorram M; Pakshir K; Tamaddon AM; Jafari M; Nouraei H; Ardekani NT; Amirzadeh N; Irajie C; Barzegar A; Iraji A; Zomorodian K
    Int J Biol Macromol; 2022 Dec; 222(Pt A):1619-1631. PubMed ID: 36183759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm.
    Pesee S; Angkananuwat C; Tancharoensukjit S; Muanmai S; Sirivan P; Bubphawas M; Tanarerkchai N
    Med Mycol; 2016 May; 54(4):384-93. PubMed ID: 26768371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
    Ng SM; Yap YY; Cheong JW; Ng FM; Lau QY; Barkham T; Teo JW; Hill J; Chia CS
    J Pept Sci; 2017 Mar; 23(3):215-221. PubMed ID: 28105725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth.
    Wibawa T; Nurrokhman ; Baly I; Daeli PR; Kartasasmita G; Wijayanti N
    Trop Biomed; 2015 Mar; 32(1):176-82. PubMed ID: 25801268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms.
    Madhavan P; Jamal F; Pei CP; Othman F; Karunanidhi A; Ng KP
    Mycopathologia; 2018 Jun; 183(3):499-511. PubMed ID: 29380188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant
    Locke JB; Almaguer AL; Donatelli JL; Bartizal KF
    Infect Dis Obstet Gynecol; 2018; 2018():7040498. PubMed ID: 29681727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.
    Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B
    Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.